Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

ClinicalTrials.gov ID: NCT05086731

Public ClinicalTrials.gov record NCT05086731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

THRIVE Smart - Leveraging Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial evaluates the feasibility and acceptability of a mobile health device in improving oral chemotherapy adherence in women with triple negative breast cancer that has not spread to other places in the body (non-metastatic). A mobile health device, called SMRxT smart pill bottle may help doctors to remind patients to take medicine on time and monitor their symptoms.

Study identification

NCT ID: NCT05086731
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Emory University; Other
Enrollment: 33 participants

Conditions and interventions

Conditions

Interventions

Best Practice Other
Informational Intervention Other
Medical Device Usage and Evaluation Other
Quality-of-Life Assessment Other
Survey Administration Other

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 22, 2021 (Actual)
Primary completion: Aug 14, 2023 (Actual)
Completion: Mar 6, 2024 (Actual)
Last update posted: Jun 17, 2025

2021 – 2024

United States locations

U.S. sites: 4
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Grady Memorial Hospital	Atlanta	Georgia	30303	—
Emory University Hospital Midtown	Atlanta	Georgia	30308	—
Emory University Hospital/Winship Cancer Institute	Atlanta	Georgia	30322	—
Emory Saint Joseph's Hospital	Atlanta	Georgia	30342	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05086731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 17, 2025 · Synced Oct 21, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05086731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →